Deciphering the Mechanistic Landscape of Immune Checkpoint Blockade in ccRCC: From Molecular Drivers to Therapeutic Responses - Top-Institutions - MDSpire

Deciphering the Mechanistic Landscape of Immune Checkpoint Blockade in ccRCC: From Molecular Drivers to Therapeutic Responses

  • By

  • Ran, Lingxiang

  • Guangmo, Hu

  • Fan, Chunyu

  • Teng, Yuanyin

  • Zhao, Rui

  • Li, Qinghua

  • Jingmin, Yang

  • Zhang, Chao

  • April 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Brigham Cancer Center
    Dana-Farber Brigham Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

Original Source(s)

Deciphering the Mechanistic Landscape of Immune Checkpoint Blockade in ccRCC: From Molecular Drivers to Therapeutic Responses

  • by Ran, Lingxiang , Guangmo, Hu , Fan, Chunyu , Teng, Yuanyin , Zhao, Rui , Li, Qinghua , Jingmin, Yang , Zhang, Chao

  • April 28, 2026

Related Content

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma